Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,823Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Meets FDA To Advance Crofelemer Trial
    Jaguar Health Meets FDA To Advance Crofelemer Trial

    06 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-06/jaguar-health-completes-meeting-with-fda-for-advice-on-development-pathways-to-advance-ongoing-crofe

    PHARMIWEB
    06 Oct 2025
    Share Share
    FDA Grants Expanded Access for Jaguar’s Crofelemer in MVID
    FDA Grants Expanded Access for Jaguar’s Crofelemer in MVID

    30 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-30/fda-authorized-expanded-access-programs-utilizing-jaguar-healths-novel-crofelemer-powder-for-oral-s

    PHARMAWEB
    30 Sep 2025
    Share Share
    Jaguar Health Gets $250k FDA Grant For Canalevia Trial In Dogs
    Jaguar Health Gets $250k FDA Grant For Canalevia Trial In Dogs

    25 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-25/jaguar-health-receives-notice-of-250-000-fda-grant-to-fund-confirmatory-trial-to-support-fda-approv

    PHARMAWEB
    25 Sep 2025
    Share Share
    Jaguar Health Seeks FDA Orphan Drug Designation for Crofelemer
    Jaguar Health Seeks FDA Orphan Drug Designation for Crofelemer

    24 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-24/jaguar-health-submits-orphan-drug-designation-application-to-fda-for-crofelemer-for-cancer-therapy-r

    PHARMAWEB
    24 Sep 2025
    Share Share
    Jaguar Health Aims to Expand Canalevia's Use at Health Summit
    Jaguar Health Aims to Expand Canalevia's Use at Health Summit

    21 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-21/jaguar-health-participating-in-august-25-26-animal-health-summit-with-goal-of-securing-collaboration

    PHARMAWEB
    21 Aug 2025
    Share Share
    Jaguar's Proposals Approved at 2025 Annual Stockholders Meeting
    Jaguar's Proposals Approved at 2025 Annual Stockholders Meeting

    19 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-19/jaguar-health-reports-approval-of-all-proposals-at-august-2025-annual-meeting-of-stockholders

    PHARMAWEB
    19 Aug 2025
    Share Share